Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    17959855 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Arsenic Trioxide in Treating Young Patients With Refractory Leukemia or Lymphoma
Conditions: Leukemia;   Lymphoma
Intervention: Drug: arsenic trioxide

Study has passed its completion date and status has not been verified in more than two years.